ivii treatment (Dexcom Inc)
Structured Review

Ivii Treatment, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivii+treatment/pmc12352713-94-11-28?v=Dexcom+Inc
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Continuous glucose monitoring during intravenous insulin infusion treatment: Assessing accuracy to enable future clinical utility"
Article Title: Continuous glucose monitoring during intravenous insulin infusion treatment: Assessing accuracy to enable future clinical utility
Journal: Diabetic Medicine
doi: 10.1111/dme.70076
Figure Legend Snippet: CEG comparison of CGM interstital fluid glucose versus reference blood glucose in people with T1D treated with IVII (a: POC; b: GAS), according to insulin infusion indication (red: DKA; blue: Non‐DKA). CEG, Consensus error grid; CGM, Continuous glucose monitoring; DKA, Diabetic ketoacidosis; GAS, Blood gas; IVII, Intravenous insulin infusion; POC, Point‐of‐care; T1D, Type 1 diabetes.
Techniques Used: Comparison
Figure Legend Snippet: Bland–Altman plot of difference between CGM interstital fluid glucose and reference blood glucose measures during IVII (a: POC; b: GAS). 95% limits of agreement (red dotted lines) calculated as mean ± 1.96 SD. CGM, Continuous glucose monitoring; GAS, Blood gas; IVII, Intravenous insulin infusion; POC, Point‐of‐care; SD, Standard deviation.
Techniques Used: Standard Deviation